Renal Cancer

Cell cycle progression score has potential prognostic value for stage T1 renal cell carcinomas. February 26, 2020

Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma. February 26, 2020

A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus. February 26, 2020

Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically. February 25, 2020

Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma. February 25, 2020

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma. February 25, 2020

Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention. February 24, 2020

MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer. February 24, 2020

A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma. February 24, 2020

Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach. February 21, 2020

Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. February 21, 2020

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium. February 21, 2020

Comparative outcomes of radio frequency ablation versus partial nephrectomy for T1 renal tumors: a systematic review. February 20, 2020

miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC). February 20, 2020

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs. February 20, 2020

Current State of Systemic Therapies for Advanced Renal Cell Carcinoma. February 19, 2020

Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells. February 19, 2020

Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma. February 19, 2020

Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma. February 18, 2020

Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft. February 18, 2020

Page 1 of 309